Lead Pharma

Sanofi, Lead Pharma partner to develop treatments for autoimmune diseases

Wednesday, February 18, 2015

Sanofi has entered into a research collaboration and license agreement with Dutch biotech Lead Pharma to discover, develop and commercialize small-molecule therapies directed against the nuclear hormone receptors called ROR gamma t to treat a broad range of autoimmune disorders, including rheumatoid arthritis, psoriasis and inflammatory bowel disease, which are among the most common.

[Read More]